Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
April 13, 2021
There has been an increasing use of digital measures in drug development recently. New wearables technologies can help...
Read article
March 31, 2021
Wearables and Decentralization
As decentralized clinical trials become more attractive in an era of COVID-19, the role of wearables in clinical...
Read article
March 26, 2021
Using External Evidence for Decision-Making for Medical Devices
Former Commissioner of the FDA, Dr. Scott Gottlieb, in several public presentations, would bemoan missed chances to...
Read article
December 5, 2019
Biotechs and Medtechs, don’t forget your market access strategy (part 4 of 4): How to optimize your market access planning approach
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel In...
Read article
December 2, 2019
Biotechs and Medtechs, don’t forget your market access strategy (part 3 of 4): Harnessing the value of market access planning
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel...
Read article
February 17, 2015
How Proposed Regulatory Reforms Will Affect Your Clinical Trial
21st Century Cures (also called Cures2015) is a bipartisan initiative undertaken by the Committee on Energy and...
Read article